Profile data is unavailable for this security.
About the company
Medica SpA is an Italy-based company primarily engaged in designing, manufacturing and supplying blood purification systems. Through subsidiaries, such as Tecnoideal sel the Company not only offers dialyzers, ultrafilters, HDF online sets, bloodlines, and pediatric dialyzers for dialysis treatment but also provides critical care CRRT equipment, hemofilter, pediatric filters, C02 removal, apheresis equipment, fractionator-cascade filtration, plasma filters, and leukocyte adsorber. It also supplies Cardiosmart, an integrated system for the treatment of patients affected by congestive heart failure; MediSulfone membrane and Purema hemoconcentration. It is engaged in water purification offering systems, including lab-pharma-industrial filtrations, individual water purifiers, and point-of-use filtrations. The Company provides infusion sets, urodynamic systems, palm bladder scanner and gastroenterology systems, among others. It operates globally.
- Revenue in EUR (TTM)79.98m
- Net income in EUR2.97m
- Incorporated1985
- Employees731.00
- LocationMedica SpAVia Degli Artigiani, 7MEDOLLA 41036ItalyITA
- Websitehttps://www.medica.it/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alligator Bioscience AB | 3.89m | -19.96m | 87.81m | 51.00 | -- | -- | -- | 22.56 | -0.362 | -0.362 | 0.0696 | -0.0125 | 0.2653 | -- | 9.47 | 788,034.50 | -136.02 | -73.26 | -367.94 | -91.33 | -- | -- | -512.61 | -811.68 | -- | -35.61 | 5.17 | -- | 62.78 | 16.60 | -28.53 | -- | -20.34 | -- |
| BenevolentAI SA | 8.69m | -75.07m | 92.75m | 248.00 | -- | 0.7095 | -- | 10.67 | -0.6371 | -0.6371 | 0.0737 | 0.9166 | 0.0473 | -- | 0.3631 | 35,046.57 | -40.88 | -- | -48.87 | -- | -- | -- | -863.69 | -- | -- | -- | 0.048 | -- | -30.58 | -- | 61.38 | -- | -- | -- |
| Adocia SA | 2.15m | -21.16m | 96.58m | 78.00 | -- | -- | -- | 44.92 | -1.93 | -1.93 | 0.194 | -0.4908 | 0.0774 | 2.62 | 7.44 | 27,564.10 | -76.16 | -43.08 | -396.14 | -72.93 | 7.91 | -- | -984.28 | -514.53 | 1.01 | -2.07 | 2.12 | -- | -81.22 | -46.13 | -206.65 | -- | -27.60 | -- |
| Eurofins-Cerep SA | 44.07m | 7.64m | 99.37m | 228.00 | 13.01 | 1.54 | 10.34 | 2.25 | 1,514.43 | 1,514.43 | 8,743.94 | 12,820.37 | 0.5864 | 1.67 | 5.08 | 193,287.10 | 10.16 | 14.21 | 12.22 | 17.51 | 85.01 | 73.61 | 17.33 | 19.77 | 4.87 | -- | 0.00005 | -- | -7.47 | 11.60 | -33.72 | 14.64 | -- | -- |
| Maat Pharma SA | 2.23m | -19.72m | 104.39m | 50.00 | -- | 4.26 | -- | 46.85 | -1.73 | -1.73 | 0.196 | 1.76 | 0.0508 | 4.84 | 4.16 | 44,560.00 | -44.99 | -35.49 | -58.93 | -42.98 | 74.28 | -- | -884.96 | -1,157.54 | 2.76 | -49.61 | 0.4075 | -- | 55.80 | -- | -43.78 | -- | 30.30 | -- |
| Arcticzymes Technologies ASA | 9.84m | 1.47m | 105.39m | 68.00 | 71.73 | 4.01 | 52.91 | 10.71 | 0.3443 | 0.3443 | 2.30 | 6.17 | 0.3562 | 0.4228 | 6.29 | 1,731,471.00 | 5.31 | 15.58 | 5.66 | 17.22 | 95.50 | 96.69 | 14.91 | 33.23 | 12.14 | -- | 0.0327 | 0.00 | -13.16 | 12.24 | -40.89 | -- | 47.93 | -- |
| Transgene SA | 7.63m | -22.33m | 107.48m | 158.00 | -- | 6.83 | -- | 14.08 | -0.2227 | -0.2227 | 0.0759 | 0.1553 | 0.1368 | -- | 4.28 | 48,316.46 | -40.00 | -24.81 | -50.27 | -29.79 | -- | -- | -292.48 | -193.24 | -- | -- | 0.4764 | -- | -23.68 | 1.51 | 31.94 | -- | 14.44 | -- |
| Scope Fluidics SA | 21.75k | -5.29m | 110.05m | 40.00 | -- | 6.35 | -- | 5,059.09 | -8.29 | -8.29 | 0.0341 | 27.18 | 0.0009 | 2.94 | 0.0337 | 2,325.00 | -21.76 | 52.74 | -22.74 | 57.32 | -2,022.58 | -420.87 | -24,304.30 | 30,134.78 | 13.86 | -- | 0.0299 | -- | 27.72 | -- | -105.76 | -- | 89.99 | -- |
| Medica SpA | 79.98m | 2.97m | 114.87m | 731.00 | 38.72 | 2.21 | 12.06 | 1.44 | 0.7025 | 0.7025 | 18.94 | 12.33 | 0.6417 | 1.39 | 5.00 | 109,410.10 | 2.00 | 4.26 | 3.17 | 6.34 | 59.45 | 63.25 | 3.12 | 7.16 | 0.8734 | 3.88 | 0.307 | -- | 57.24 | 19.52 | -31.80 | 2.05 | 24.28 | -- |
| Inventiva SA | 17.48m | -110.43m | 117.81m | 112.00 | -- | -- | -- | 6.74 | -2.45 | -2.45 | 0.3854 | -0.6146 | 0.1884 | -- | 9.18 | 156,044.60 | -116.84 | -54.30 | -207.08 | -69.98 | -- | -- | -620.31 | -669.97 | 0.9524 | -19.98 | 6.96 | -- | 43.50 | 40.46 | -103.46 | -- | -0.33 | -- |
| Oryzon Genomics SA | 0.00 | -2.87m | 120.09m | 44.00 | -- | 1.40 | -- | -- | -0.0431 | -0.0431 | 0.00 | 1.34 | 0.00 | 101.09 | -- | 0.00 | -2.72 | -4.20 | -3.19 | -4.82 | -- | -- | -- | -- | 0.8741 | -3.16 | 0.1487 | -- | -- | -- | 20.76 | -- | 15.52 | -- |
| Futura Medical PLC | 3.68m | -7.72m | 121.05m | 12.00 | -- | 18.61 | -- | 32.93 | -0.0219 | -0.0219 | 0.0105 | 0.0182 | 0.3391 | -- | 5.09 | 258,414.20 | -71.22 | -79.25 | -127.75 | -127.22 | 57.22 | -- | -210.03 | -914.37 | 1.47 | -- | 0.00 | -- | -- | -- | -11.40 | -- | 219.68 | -- |
| Heidelberg Pharma AG | 9.52m | -13.06m | 123.04m | 97.00 | -- | 2.99 | -- | 12.92 | -0.2837 | -0.2837 | 0.2062 | 0.8832 | 0.1270 | 0.194 | 13.23 | 100,234.60 | -17.42 | -43.91 | -22.34 | -64.34 | 82.74 | 52.13 | -137.16 | -206.24 | 4.90 | -- | 0.3417 | -- | -46.75 | 21.87 | -3.27 | -- | -0.8341 | -- |
| Diamyd Medical AB | 15.84k | -11.89m | 143.84m | 25.00 | -- | 8.90 | -- | 9,078.85 | -1.55 | -1.55 | 0.0021 | 1.96 | 0.0009 | -- | 3.35 | 7,440.00 | -68.99 | -25.46 | -76.65 | -28.37 | -7,386.02 | -1,419.23 | -75,065.59 | -5,896.43 | -- | -90.74 | 0.1391 | -- | 20.26 | -5.54 | -12.13 | -- | -- | -- |
| Cellectis SA | 11.17m | -72.23m | 145.81m | 235.00 | -- | 1.74 | -- | 13.05 | -1.22 | -1.03 | 0.1639 | 1.16 | 0.04 | -- | 1.41 | 47,550.21 | -27.82 | -24.08 | -42.40 | -30.69 | -- | -64.64 | -694.72 | -308.24 | -- | -- | 0.552 | -- | -64.26 | -15.57 | -20.55 | -- | -26.15 | -- |
Data as of Jul 26 2024. Currency figures normalised to Medica SpA's reporting currency: Euro EUR
8.53%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Azimut Capital Management SGR SpAas of 28 Jun 2024 | 270.85k | 6.41% |
| IMPact SGR SpAas of 28 Mar 2024 | 54.00k | 1.28% |
| MOMentum Alternative Investments SAas of 31 Mar 2024 | 14.00k | 0.33% |
| Banor SIM SpAas of 31 Mar 2024 | 10.70k | 0.25% |
| Link Fund Solutions (Luxembourg) SAas of 31 Jan 2024 | 9.50k | 0.23% |
| GVC Gaesco Gesti�n SGIIC SAas of 31 Mar 2024 | 550.00 | 0.01% |
| Investitori SGR SpAas of 28 Jun 2024 | 450.00 | 0.01% |
| Sella SGR SpAas of 28 Jun 2024 | 50.00 | 0.00% |
More ▼
Data from 28 Mar 2024 - 28 Jun 2024Source: FactSet Research Systems Inc.
